Attis Provides an Update on Status of Nasdaq Listing
October 15 2019 - 4:30PM
via NEWMEDIAWIRE -- Attis Industries Inc. (NASDAQ: ATIS) (the
“Company” or “Attis”), a diversified innovation and technology
holding company, today announced that the Nasdaq Capital Market
(the “Exchange”) has informed the Company by letter (the “October
Nasdaq Letter”) that it is not in compliance with the Exchange’s
continued listing requirements as set forth in Nasdaq Listing Rule
5550 (a)(2). This is a result of the Company’s minimum bid
price falling below $1.00 per share for a period of thirty (30)
consecutive business days, however this notification will have no
immediate effect on the listing or trading of the common stock on
the Exchange. Under the Nasdaq Listing Rule 581(c)(3)(A), the
Company is provided a period of 180 days in which it may regain
compliance.
The Company disagrees with the public market’s perceived per
share value of its common stock but believes that it is the result
of a delay in completing its required public filings with the
Securities and Exchange Commission. The Company continues to
work diligently with its independent accounting firm to expediently
complete the delinquent filings with the confidence that once these
filings are current its minimum bid share price will come back
within compliance.
Attis Industries, Inc.
Attis Industries Inc. (NASDAQ: ATIS) is a
diversified innovation and technology holding company focused on
developing and building businesses in the healthcare, sustainable
materials and renewable fuel markets. We strive to encourage our
employees to be entrepreneurs focused on innovation and technology.
We will remain dynamic, persistent and motivated to our mission of
winning. The growth of our company will rely on our integrity and
our vision for the future. Today, each of Attis business sectors
provide high growth opportunities that collectively account for
more than a third of our nations GDP. For more information, visit:
www.attisind.com
Forward-Looking Statements
Any statements contained in this press release
that do not describe historical facts may constitute
forward-looking statements as that term is defined in the Private
Securities Litigation Reform Act of 1995. You can identify
forward-looking statements by words such as “anticipate,”
“believe,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,”
“should,” “would” or similar words. You should consider these
statements carefully because they discuss our plans, targets,
strategies, prospects and expectations concerning our business,
operating results, financial condition and other similar matters.
These statements are subject to certain risks, uncertainties, and
assumptions, including, but not limited to, risks and uncertainties
relating to the Company's ability to develop, market and sell
products based on its technology; the expected benefits and
efficacy of the Company's products and technology; the availability
of substantial additional funding for the Company to continue its
operations and to conduct research and development, clinical
studies and future product commercialization; and, the Company's
business, research, product development, regulatory approval,
marketing and distribution plans and strategies; the ability of the
Company to continue to meet the listing requirements of NASDAQ; the
ability of the Company to execute on a business plan that permits
the technologies and innovations businesses to provide sufficient
growth, revenue, liquidity and cash flows for sustaining the
Company’s go-forward business, and the risks identified and
discussed under the caption “Risk Factors” in the Attis Annual
Report on Form 10-K for the fiscal year ended December 31, 2017,
filed with the Securities and Exchange Commission (the “SEC”) on
April 16, 2018 and the other documents Attis files with the SEC
from time to time. There will be events in the future, however,
that Attis is not able to predict accurately or control. Attis’s
actual results may differ materially from the expectations that
Attis describes in its forward-looking statements. Factors or
events that could cause Attis’s actual results to materially differ
may emerge from time to time, and it is not possible for Attis to
accurately predict all of them. Any forward-looking statement made
by Attis in this press release speaks only as of the date on which
Attis makes it. Attis undertakes no obligation to update or revise
any forward-looking statements, whether as a result of new
information, future events or otherwise, except as required by
law.
Corporate Investor Relations:
ir@attisind.com
Attis Industries (NASDAQ:ATIS)
Historical Stock Chart
From Nov 2024 to Dec 2024
Attis Industries (NASDAQ:ATIS)
Historical Stock Chart
From Dec 2023 to Dec 2024